Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
69.71
-0.19 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
Belite Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | - | -31.63 | -12.65 | -9.67 | -5.75 |
Depreciation & Amortization | - | 0.4 | 0.2 | 0.03 | 0.02 |
Loss (Gain) From Sale of Assets | - | - | - | -0.01 | - |
Stock-Based Compensation | - | 3.82 | 1.48 | 1.53 | 1.36 |
Change in Accounts Receivable | - | -0.02 | -0.03 | - | 0 |
Change in Accounts Payable | - | - | -0.04 | 0.05 | -0.02 |
Change in Other Net Operating Assets | - | -2.41 | -0.42 | 0.6 | -0.05 |
Operating Cash Flow | - | -29.84 | -11.46 | -7.47 | -4.44 |
Capital Expenditures | - | -0.06 | -0.39 | -0.07 | -0.02 |
Sale of Property, Plant & Equipment | - | - | - | 0.02 | - |
Investing Cash Flow | - | -0.06 | -0.39 | -0.06 | -0.02 |
Short-Term Debt Issued | - | - | - | - | 0.13 |
Total Debt Issued | - | - | - | - | 0.13 |
Short-Term Debt Repaid | - | - | - | - | -2.45 |
Total Debt Repaid | - | - | - | - | -2.45 |
Net Debt Issued (Repaid) | - | - | - | - | -2.32 |
Issuance of Common Stock | - | 77.19 | 37.99 | 0.23 | 0.59 |
Other Financing Activities | - | -1.23 | -1.03 | -0.82 | - |
Financing Cash Flow | - | 75.96 | 36.96 | -0.58 | 28.06 |
Foreign Exchange Rate Adjustments | - | 0.01 | -0.37 | -0.16 | 0 |
Net Cash Flow | - | 46.07 | 24.75 | -8.27 | 23.6 |
Free Cash Flow | - | -29.9 | -11.85 | -7.55 | -4.46 |
Free Cash Flow Per Share | - | -1.12 | -0.59 | -0.79 | -0.51 |
Cash Interest Paid | - | - | 0.02 | - | 0.02 |
Levered Free Cash Flow | - | -15.3 | -7.1 | -4.01 | - |
Unlevered Free Cash Flow | - | -15.28 | -7.09 | -4.01 | - |
Change in Net Working Capital | 55.86 | -0.35 | 0.36 | -0.63 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.